Two independent genome-wide analyses confirmed the hypermethylation of the aberrant SALL1 promoter in human samples of acute lymphocytic leukemia (ALL) and chronic lymphocytic leukemia (CLL). The gene discussed is SALL1; the disease is B-cell chronic lymphocytic leukemia.